Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer.

Main|Search|PHGKB



Last Posted: Jun 29, 2018

---

• Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer.  
  Murali Rajmohan et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Feb (2) 201-209
• The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.  
  McAlpine Jessica et al. The Journal of pathology 2018 Apr (5) 538-549
• Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).  
  Leenders Erika K S M et al. European journal of human genetics : EJHG 2018 Jun
• The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma  
  A Wang et al, Health Services Reports, June 2018
• A Pap-Based Test to Detect Endometrial and Ovarian Cancers Early.  
  Abbasi Jennifer et al. JAMA 2018 May 319(18) 1853
• Biotech Firm Takes The First Steps In Its Quest For A Blood Test For Cancer  
  M Herper, Forbes, June 2, 2018
• Endometrial cancer: Molecular markers and management of advanced stage disease.  
  Arend Rebecca C et al. Gynecologic oncology 2018 May
• Genomic Markers Can Predict the Presence of Lynch Syndrome across a Broad Spectrum of Cancers  
  MSKCC, June 2, 2018
• MSI-H Status May Predict Lynch Syndrome Across Varied Tumor Types  
  ASCO Daily News, June 4, 2018
• Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.  
  Yokoyama Takanori et al. BMC cancer 2018 May 18(1) 576

more